21 May 2009
Forensic medicine methods allow to detect donor dna in recipient blood for years after kidney transplantation
J Rutkowska, M Zagozda, R Ginak, A Rydzewski, M Swietek, M Durlik, W OlszewskiAnn Transplant 2009; 14(1): 36-36 :: ID: 880329
Abstract
Background: After organ transplantation DNA from passenger cells and
ischemia and rejection damaged cells is disseminated in the recipient. The
question is whether this DNA may be incorporated into recipient cell genome in the process of the so called "illegitimate DNA incorporation" - a frequent phenomenon in nature. Aim: To search for the donor DNA in recipient tissues and cells after allogeneic transplantation and immunosuppression.
Material/Methods: Recipient's blood samples were collected before and after kidney transplantation on 1,14,28,90,180,360 and 720 days and genomic DNA was isolated. Short tandem repeats analysis (STR) was applied. The investigated loci were: phospholipase A2-HUMPLA2A1(AAT)n, cytochrome P450 HUMCYARO(AAAT)n and D1S80.
Results: Donor cytochrome P450 or HUMPLA2 or D1S80 genes were detected
in recipient blood cells up to 2 years after kidney transplantation. Positive results were observed 24hr after grafting in 3 out of 3pts and in 4 out of 4 pts after 14
days, in 28 out of 28 after 28, in 2 out of 2 after 90, in 3 after 180, in 1 after 1 and in 2 out of 2 after 2 years.
Conclusions: Donor DNA can be detected in recipient blood cells 2 years after kidney transplantation. The question as to whether the detected donor DNA was contained in the surviving donor cells or in a form of apoptotic or necrotic bodies in recipient phagocytes or whether was incorporated into recipient cell genome remains to be answered. Recent study documents show the presence of the donor DNA in the nuclei of recipient's APCs.
Keywords: Kidney Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






